First line of biological drugs in rheumatoid arthritis: a medication persistence analysis.

Jéssica Barreto Ribeiro Dos Santos Augusto Afonso Guerra Junior Michael Ruberson Ribeiro da Silva Alessandra Maciel Almeida Francisco de Assis Acurcio Juliana Álvares Teodoro

Published in: Expert review of clinical pharmacology (2019)

The medication persistence was different between biological drugs. The rigorous follow-up of patients, by a multidisciplinary team, is important to enable the development of strategies for the adequate use of such drugs.

Keyphrases

rheumatoid arthritis
end stage renal disease
ejection fraction
healthcare
newly diagnosed
chronic kidney disease
prognostic factors
quality improvement
emergency department
drug induced
systemic lupus erythematosus
patient reported outcomes